Jan 18, 2025, 07:50
Timing of ADT in patients with prostate cancer with a rising PSA
A recent paper by Gillian Duchesne et al. was mentioned by Akhil Santhosh, Medical Oncologist at AIIMS Delhi, on X:
“Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
For rising psa post local therapy, immediate ADT has OS benefit.”
Authors: Gillian Duchesne, Henry Woo, Julie Bassett, Keen Hun Tai, Sandra Turner et al.
More posts featuring Akhil Santhosh.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 18, 2025, 07:50
Jan 18, 2025, 07:42
Jan 18, 2025, 07:33
Jan 18, 2025, 07:20
Jan 18, 2025, 07:15
Jan 18, 2025, 06:41
Jan 18, 2025, 06:34
Jan 18, 2025, 00:00